These findings pave the way for targeting ERK1/2 as a promising strategy to selectively inhibit TGF-β-induced invasion and metastasis in iCCA cells, without impairing its cytostatic activity [21]. This evidence concerns the gene TGFB1 and infantile convulsions and choreoathetosis.